AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $82.94
- 52-wk low
- $32.89
- Prev close
- $56.77
- Mkt cap
- $6.30B
- P/E
- 81.6x
- Fwd P/E
- 74.6x
Smart money
Earnings
Earnings came in 16.7% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $180.9M | $202.1M | $214.3M | $243.6M |
| Cost of what it sold | $83.6M | $91.1M | $96.4M | $111.6M |
| Gross profit | $97.3M | $111.0M | $117.9M | $132.0M |
| What it spent | ||||
| Research and development | $24.1M | $34.6M | $27.5M | $40.9M |
| Sales and admin | $49.1M | $56.8M | $61.2M | $63.9M |
| Total operating expenses | $73.2M | $91.3M | $88.6M | $104.8M |
| What was left | ||||
| Operating profit | $24.0M | $19.8M | $29.3M | $27.2M |
| Profit before tax | $27.2M | $23.3M | $32.7M | $31.1M |
| Tax | $8.7M | $9.1M | $10.1M | $5.7M |
| Net profit | $18.4M | $14.2M | $22.6M | $25.4M |
| EBITDA | $27.5M | $23.7M | $33.1M | $27.7M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
2 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Kiniksa Pharmaceuticals International, plc Class A Revenue Breakdown – BIVA:KNSA/N
Leans bullishAug 15Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (NASDAQ:KNSA)
BullishAug 10
